GC Therapeutics

BiotechnologySeries ACambridge, USgc-tx.com

Latest round

Series A

Last raised

Sep 2024

Total raised

$65M

Investors

6

About GC Therapeutics

Based in Massachusetts, US, and founded in 2019 by Alex Ng (CSO), Cory Smith, George Church, and Parastoo Khoshakhlagh (CEO), GC Therapeutics Inc. operates as a biotechnology research company focusing on synthetic biology and cell therapy. In September 2024, GC Therapeutics, Inc. The firm develops advanced cell therapies using its TFome™ platform, which utilizes induced pluripotent stem cells (iPSCs) to produce therapeutic cells. The technology helps simplify the complexities of cell therapy, allowing for the rapid development and scaling of treatments—potentially achieving improvements in speed, potency, and cost-effectiveness compared to traditional methods. GCTx is targeting therapeutic applications in gastrointestinal, neurological, and immunological diseases.

Who invested in GC Therapeutics

6 investors across 1 round

See all investors in GC Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 19, 2024

    Amount

    $65M

    Investors

    Locked

Questions about GC Therapeutics

Who invested in GC Therapeutics?

GC Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has GC Therapeutics raised?

GC Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did GC Therapeutics last raise money?

GC Therapeutics's most recent round on record is a Series A, in Sep 2024.

What does GC Therapeutics do?

Based in Massachusetts, US, and founded in 2019 by Alex Ng (CSO), Cory Smith, George Church, and Parastoo Khoshakhlagh (CEO), GC Therapeutics Inc.

Where is GC Therapeutics headquartered?

GC Therapeutics is headquartered in Cambridge, US.

Which VCs invest in companies like GC Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at GC Therapeutics's stage. Their profiles are linked below.

Raising like GC Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.